| Financial Year |
March 31 2023 |
| Monetary Funds |
2,142,597,148.09 |
| Held-for-trading Financial Assets |
240,362,881.08 |
| Notes Receivable |
-- |
| Accounts Receivable |
41,083,148.26 |
| Advances to Suppliers |
36,283,963.71 |
| Other Receivables |
12,348,057.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
134,257,051.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,437,305.18 |
| Total Current Assets |
2,628,369,554.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,304,066.90 |
| Investment Properties |
79,296,439.61 |
| Fixed Assetes |
1,558,564,061.93 |
| Under-construction Projects |
51,315,341.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
192,994,159.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,042,961.91 |
| Deferred Income Tax Assets |
110,057,847.50 |
| Other Non-Current Assets |
5,076,005.19 |
| Sub-Total of Non-Current Assets |
2,053,996,795.86 |
| Total Assets |
4,682,366,350.66 |
| Short-Term Loans |
971,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
224,693,000.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
59,952,234.18 |
| Taxes Payable |
36,409,772.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,255,706.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,466,267.63 |
| Other Current Liabilities |
7,655,950.32 |
| Sub-Total of Current Liabilities |
1,469,768,301.46 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,148,266.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,427,539.59 |
| Total Liabilities |
1,552,195,841.05 |
| Paid-In Capital(Or Share Stock) |
410,745,800.00 |
| Capital Surplus |
633,063,138.17 |
| Surplus Reserve |
207,556,900.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,876,281,211.24 |
| Minority Stockholder's Interest |
2,523,460.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,127,647,049.41 |
| Owner's Equity（Stockholder's Equity） |
3,130,170,509.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,682,366,350.66 |
